An increasing ability to identify tumour antigens, coupled with advances in immunization, has generated new enthusiasm for cancer vaccination strategies. Cancer Vaccines and Immunotherapy describes the underlying mechanisms and the therapeutic potential of this approach.
The short and lucid introduction is essential for an understanding of what follows: it deals with immunosurveillance and how it may be affected in cancer, with immune-mediated elimination of allogeneic tumours in animal models, with the successful treatment of Epstein± Barr virus related lymphoma in renal transplant patients by infusion of immune T cells, and with the way the immune system recognizes and processes tumour antigens, what induces self-tolerance, and which additional molecules are required for an effective immune response. A chapter on pox viruses, one of the principal delivery vehicles for tumour vaccines, serves as useful background to the discussion of clinical trials.
The hope, of course, is that vaccination will improve on the results of conventional therapies, especially for common tumours such as breast cancer. In this respect there has been much interest in the MUC1 gene, which encodes for an epithelial mucin overexpressed in malignant breast cells and associated with an altered pattern of glycosylation (though the relevance of this to cell behaviour is unknown). MUC1 can also act as a ligand for the adhesion molecule ICAM-1 and enhances antigen presentation to T cells, possibly via interaction with a lectin molecule. A multitude of antibodies have been raised to MUC1 and some are being used in clinical trials of immunotherapy for breast and ovarian cancer. Early results are promising and phase III studies are underway.
One of the key chapters deals with an approach termed SEREX (serological analysis of tumour antigens by recombinant cDNA expression cloning). This involves the construction of cDNA expression libraries from fresh tumour specimens and the selection of clones that elicit high-titre IgG antibody responses. Some of the advantages of this technique are that tumour lines do not have to be established, identi®ed genes are expressed in vivo and multiple antigens can be identi®ed with one screening course and sequenced immediately. By 1998 there were over nine hundred entries on the SEREX database. This technique may allow mapping of the antigenic pro®le of individual tumours, identi®cation of the antigens that elicit an immune response in cancer patients, and the development of polyvalent vaccines.
Although techniques of this kind offer hope that novel treatments will soon emerge, the overview in Cancer Vaccines and Immunotherapy sounds some notes of caution. Of the antigens identi®ed by SEREX few have reached the stage of preclinical trial, so the full limitations of the method have probably yet to emerge. Of the various delivery mechanisms for vaccines, all have advantages and disadvantages. And the remaining challenge is to optimize the design of clinical trials to ensure that vaccines are not only immunogenic and effective but also safe. This requires development of better tools for assessing immunological and clinical aspects. The choice of malignant target and stage of disease is also important.
Despite all the scienti®c advances there is still no certainty that cancer vaccines will work ef®ciently. The vaccine for which the evidence is strongest, BCG for bladder cancer, is based on the old non-speci®c approach. But there is suf®cient evidence in this valuable survey to warrant a degree of optimism. Medicine is under intensive public scrutiny and increasingly the law impinges on practice. Busy medical professionals cannot cope with textbooks full of legal jargon; Dr Branthwaite, a medically quali®ed barrister, has come to our aid with a book that is non-technical, easy-¯owing, non-taxing to the brain yet thoroughly relevant.
After a brief introduction to English law, she begins with a general view of what constitutes negligence in both hospital and private practice and on the general standards and duty of care expected of health professionals. The notion of foreseeability and failure to act resulting in injury is clearly stated. The matter of ®nancial compensation is also described and one gathers that courts are more likely to compensate physical than mental or social injury. The next chapter is devoted to litigation and the steps by which it is undertaken and resolved (with a good view of the different courts and the important role of the expert witness). Particularly eye-opening is the section on pre-action protocol and alternative dispute resolution, two methods that can be attempted before the dispute comes to court. A chapter on con®dentiality and disclosure discusses the circumstances in which medical records can be disclosed. The next section deals mainly with consent and the special dif®culties in relation to children and the mentally handicapped. We are also reminded about the importance of proper informed consent in research. National Health Service complaints, disciplinary proceedings and`whistleblowing' are discussed next. The actions that may be taken by employing authorities and the General Medical Council (GMC) are well illustrated, and this section is particularly informative on the role of the ®ve committees of the GMC regarding ®tness to practise. The ®nal two chapters deal with coroners' courts and criminal law in relation to doctors, the last describing circumstances of conviction for homicide and manslaughter. Of relevance here is the section on criminal liability for end-of-life decisionsÐwithdrawal of nutrition, hydration and life support.
Dr Branthwaite has clearly made a great effort to avoid complex legal terminology and her book is thoroughly readable. It has dispelled a lot of my uneasiness and concern which was founded on uncertainty. For anyone who seeks basic information on the medicolegal aspects of day-to-day medicine this is a book to go for. Fifty years ago every one of London's teaching hospitals had on its staff a consultant gynaecologist trained by Victor Bonney, so great was his in¯uence and so successful his methods of training gynaecological surgeons. How did this small, dapper man do it? In a beautifully written biography Geoffrey Chamberlain explains much about Bonney's special style and skills.
Parijat De
Bonney was born in West London in 1872: both his father and his paternal grandfather were family doctors. In describing Bonney's life Chamberlain has seamlessly linked his chronology with the events of the late 19th and of the 20th century during which two world wars were fought and many great political and social changes occurred.
Bonney's professional achievements and his fame among colleagues were ®rstly for his extraordinary performance of 500 Wertheim radical extended hysterectomy operations for cancer of the cervix and, secondly, for his development of the conservative operations of myomectomy and ovarian cystectomy. His radical hysterectomy saved the lives of many women who would otherwise have died from painful and debilitating cancer of the cervix; and his conservative operations preserved the fertility of many women who would otherwise have been childless. His motivation for the development of the second type of operation was the experience of his wife Annie, who became grossly anaemic from heavy menstrual periods and underwent a hysterectomy, the only treatment then known. So within two years of marriage she was made sterile. Ten days after the operation Annie's bowel obstructed. A great surgeon Bland Sutton dealt with that. Bonney inevitably became interested in conservative surgery and in bowel function after major surgery; so in the end he developed not only the operation of myomectomy to remove ®broids and conserve the uterus, but also ovarian cystectomy to remove nonmalignant cysts while conserving ovaries.
Chamberlain has managed to detail the events of Bonney's professional and social life in context with the very dramatic world events that occurred in his life. In the First World War Bonney and his consultant colleague Comyns Berkeley were, because of the work they were
